MedCity News March 28, 2022
To get to the root of existing reimbursement problems, health plans should consider tackling genomic benefits management in a way that addresses test ordering and billing challenges.
Although genomic testing has been around for decades, the volume of available tests is increasing at an unprecedented rate. There are more than 150,000 tests on the market today, and new ones are arriving weekly. That makes it tough to stay abreast of all the changes and know what has clinical utility and in which scenarios.
While many genomic tests offer known benefits, there are lots of tests with unproven clinical utility; different types of tests for the same indication without clear information describing the differences and their potential impact; different types of...
Today's Sponsors
Today's Sponsor